{"entity":{"type":"insider","cik":"0001334248","url":"/insider/0001334248","json_url":"/insider/0001334248.json","name":"Aberdare Partners III LP","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":4,"n_filings":1,"first":"2013-08-01","last":"2013-08-01","span_basis":"filed_date"},"name_variants":[{"name":"Aberdare Partners III LP","source":"filing","n_filings":1,"first_seen":"2013-08-01","last_seen":"2013-08-01"}],"transactions":[{"id":5399480,"accession":"0001209191-13-038817","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001209191-13-038817","line_url":"/filing/0001209191-13-038817","is_derivative":false,"issuer_cik":"0001313414","issuer_name":"Conatus Pharmaceuticals Inc","issuer_ticker":"CNAT","issuer_name_source":null,"issuer_url":"/issuer/0001313414","owner_cik":null,"owner_name":"Aberdare Partners III LP; Aberdare GP III, L.L.C.; Aberdare Ventures III LP","owner_display_name":"Aberdare Partners III LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":566.0,"shares_display":"566","price_per_share":11.0,"price_display":"11.00","price_state":"stated","total_value":6226.0,"total_display":"6,226.00","total_whole":"6,226","shares_owned_after":2111378.0,"shares_owned_after_display":"2,111,378","ownership_form":"I","is_10b5_1":null,"transaction_date":"2013-07-30","filed_date":"2013-08-01","scope":"insider","n_lines":2},{"id":5399476,"accession":"0001209191-13-038817","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001209191-13-038817","line_url":"/filing/0001209191-13-038817","is_derivative":false,"issuer_cik":"0001313414","issuer_name":"Conatus Pharmaceuticals Inc","issuer_ticker":"CNAT","issuer_name_source":null,"issuer_url":"/issuer/0001313414","owner_cik":null,"owner_name":"Aberdare Partners III LP; Aberdare GP III, L.L.C.; Aberdare Ventures III LP","owner_display_name":"Aberdare Partners III LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":107422.0,"shares_display":"107,422","price_per_share":11.0,"price_display":"11.00","price_state":"stated","total_value":1181642.0,"total_display":"1,181,642.00","total_whole":"1,181,642","shares_owned_after":2226944.0,"shares_owned_after_display":"2,226,944","ownership_form":"I","is_10b5_1":null,"transaction_date":"2013-07-30","filed_date":"2013-08-01","scope":"insider","n_lines":2}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":0,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":0},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001383701","name":"Conatus Pharmaceuticals Inc","url":"/issuer/0001383701","role":"Ten percent owner","n_filings":1,"first_seen":"2013-08-01","last_seen":"2013-08-01"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001334248","retrieved_at":"2026-08-22T11:59:16+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}